Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
1.12
-0.04 (-3.45%)
At close: Sep 08, 2025, 3:59 PM
1.08
-3.57%
After-hours: Sep 08, 2025, 05:12 PM EDT
-3.45% (1D)
| Bid | 1.08 |
| Market Cap | 11.63M |
| Revenue (ttm) | 61.56M |
| Net Income (ttm) | -31.79M |
| EPS (ttm) | -1.8 |
| PE Ratio (ttm) | -0.62 |
| Forward PE | -1.06 |
| Analyst | n/a |
| Ask | 1.16 |
| Volume | 286,296 |
| Avg. Volume (20D) | 5,235,933 |
| Open | 1.12 |
| Previous Close | 1.16 |
| Day's Range | 1.08 - 1.15 |
| 52-Week Range | 0.48 - 3.44 |
| Beta | 0.96 |
About TRIB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRIB
Website n/a
Next Earnings Release
Trinity Biotech is scheduled to release its earnings on
Sep 19, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+27.01%
Trinity Biotech shares are trading higher after th...
Unlock content with
Pro Subscription
3 weeks ago
+89.11%
Trinity Biotech shares are trading higher after the company announced it received regulatory approval to begin FDA-cleared PreClara Preeclampsia Testing service.
